Ophthalmic Devices - United Arab Emirates

The projected revenue in the Ophthalmic Devices market market in the United Arab Emirates is estimated to reach US$229.40m in 2024.
It is expected to grow at an annual growth rate of 9.18% (CAGR 2024-2029), resulting in a market volume of US$355.90m by 2029.
In terms of global comparison, the United States is anticipated to generate the highest revenue, reaching US$14.00bn in 2024.
The United Arab Emirates is experiencing a growing demand for advanced ophthalmic devices to meet the healthcare needs of its population.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in United Arab Emirates has been experiencing significant growth in recent years.

Customer preferences: Customers in United Arab Emirates have shown a strong preference for technologically advanced ophthalmic devices. They are willing to invest in high-quality products that offer superior performance and accuracy. Additionally, customers in this region value products that are aesthetically pleasing and comfortable to use. They also prioritize products that are easy to maintain and have a long lifespan.

Trends in the market: One of the key trends in the Ophthalmic Devices market in United Arab Emirates is the increasing demand for refractive surgery devices. With a growing number of people seeking vision correction procedures, there is a rising need for advanced devices that can deliver precise and effective results. Laser-assisted in situ keratomileusis (LASIK) devices, in particular, are in high demand due to their ability to correct various refractive errors. Another trend in the market is the rising adoption of diagnostic devices. Ophthalmologists and optometrists in United Arab Emirates are increasingly using advanced diagnostic tools to accurately assess and diagnose eye conditions. Optical coherence tomography (OCT) devices, for example, are being widely used for the diagnosis and monitoring of various retinal diseases.

Local special circumstances: United Arab Emirates has a high prevalence of certain eye conditions, such as cataracts and glaucoma. This has created a significant demand for ophthalmic devices that can effectively diagnose and treat these conditions. Additionally, the country has a rapidly growing elderly population, which further contributes to the demand for ophthalmic devices.

Underlying macroeconomic factors: The Ophthalmic Devices market in United Arab Emirates is influenced by several macroeconomic factors. The country has a strong economy and high disposable income levels, which enable individuals to afford expensive ophthalmic devices. Furthermore, the government of United Arab Emirates has been actively promoting healthcare infrastructure development, including the establishment of specialized eye care centers. This has created a favorable environment for the growth of the Ophthalmic Devices market in the country. In conclusion, the Ophthalmic Devices market in United Arab Emirates is witnessing significant growth due to customer preferences for technologically advanced devices, the increasing demand for refractive surgery and diagnostic devices, the high prevalence of eye conditions, and the favorable macroeconomic factors. As the market continues to evolve, it is expected that manufacturers will focus on developing innovative products to cater to the specific needs and preferences of customers in United Arab Emirates.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.